Am J Transplant, Volume 17, Suppl 3 Archives - Page 154 of 181 - ATC Abstracts

2017 American Transplant Congress
Identifying Risks and Screening Deceased Organ Donors in the UK for Trypanosoma cruzi .
I. Ushiro-Lumb,^1,2 M. Webster,¹ A. Kitchen.¹
¹Microbiology Services, NHS Blood and Transplant, London, United Kingdom; ²Virus Reference Department, Public Health England, London, United Kingdom
Background: In the UK, the Advisory Committee on Microbiological Safety of Blood, Tissues and Organs recommends discretionary T. cruzi antibody screening of donors with identified…
2017 American Transplant Congress
Dual Role for Caspase-3 in the Regulation of Tubular and Microvascular Damage Post-Renal Ischemia-Reperfusion Injury.
B. Yang,^1,2,3 S. Lan,^1,2,3 N. Patey,^1,3,4 J. Turgeon,^1,3 M. Dieudé,^1,3 M.-J. Hébert.^1,2,3
¹Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada; ²Canadian National Transplant Research Program, Edmonton, AB, Canada; ³Université de Montréal, Montreal, QC, Canada; ⁴Department of Pathology, CHU Ste-Justine, Université de Montréal, Montreal, QC, Canada
Ischemia-reperfusion injury (IRI) in renal transplant recipients is a risk factor of allograft dysfunction and reduced survival. Although tubular epithelial cells (TEC) are classically considered…
2017 American Transplant Congress
Predictive Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy After Kidney Transplantation.
N. Maillard,¹ H. Suzuki,² H. Mohey,¹ C. Mariat,¹ J. Novak,³ B. Julian,⁴ F. Berthoux.¹
¹Nephrology, Dialysis and Renal Transplantation, CHU Saint Etienne, Saint Etienne, France; ²Division of Nephrology, Department of Internal Medicine, Juntendo University, Tokyo, Japan; ³Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL; ⁴Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
The recurrence of IgA nephropathy (IgAN) after kidney transplantation is frequent and can cause graft losses. The prediction of the recurrence cannot be performed from…
2017 American Transplant Congress
Acute Rejection in 6 Antigen HLA Matched Kidney Transplant Recipients: Risk Factors and Outcomes.
A. Condon, B. Astor, K. Holdener, T. Ellis, A. Djamali.
University of Wisconsin Health, Madison, WI
Background: Acute rejection in HLA matched kidney transplant recipients is uncommon, and the mechanisms involved are not well understood.Methods: Data from 6 antigen HLA matched…
2017 American Transplant Congress
Clinical and Pathologic Characteristics of Acute Rejection After Alemtuzumab Induction in Kidney Transplant Recipients.
P. Zhang,¹ H. Amer,² C. Schinstock,² M. Alexander,¹ F. Cosio,² M. Stegall,³ L. Cornell.¹
¹Anatomic Pathology, Mayo Clinic, Rochester; ²Nephrology, Mayo Clinic, Rochester; ³Transplant Surgery, Mayo Clinic, Rochester
Background: Alemtuzumab induction (AZI) can be used for early steroid withdrawal in kidney transplant (KTx) recipients. There is evidence that AZI-induced lymphocyte depletion leads to…
2017 American Transplant Congress
Infections and Outcomes in Renal Transplantation Patients Using Alemtuzumab for Induction Immunosuppression: Preliminary Results.
K. Korneffel, B. Gehring, G. Mitro, O. Aboderin, S. Makkar, W. Han, M. Rees, J. Ortiz.
Surgery, University of Toledo College of Medicine, Toledo, OH
Introduction: Alemtuzumab (Ale) is a monoclonal antibody targeting CD52+ lympocytes. We sought to determine the impact of Ale immunodepletion, with steroid freedom for low risk…
2017 American Transplant Congress
Predictive Value of Post Reperfusion TEG in Peri-Operative Outcomes During Liver Transplant.
P. Sheiner, A. Sulejamnovic, J. Salm, E. Silver, C. Rochon.
Transplant Surgery, Hartford Hospital, Hartford, CT
Liver transplantation (LT) is the main treatment for patients with end-stage liver disease. During a liver transplant, persistent coagulations defects and fibrinolysis can be an…
2017 American Transplant Congress
Diabetes in Liver Transplantation: Evaluation of Management and Associated Clinical Outcomes.
A. Rogers,² N. Patel,² H. Meadows,² A. Mardis,² J. Fleming,² C. Perez,² I. Lee,² M. Sell,² B. O'Brien,² D. Taber,¹ K. Chavin,¹ D. Dubay,¹ C. Mardis,² N. Pilch.¹
¹Department of Surgry Division of Transplant, Medical University of South Carolina, Charleston, SC; ²Department of Pharmacy, Medical University of South Carolina, Charleston, SC
PurposeThere is limited data with diabetes management in liver transplant recipients and associated outcomes, this study aims to evaluate the long-term diabetes management in this…
2017 American Transplant Congress
Technique and Result of Anastomosing Right Hepatic Vein to Inferior Vena Cava with a Separate Cavotomy Inferior to Right Hepatic Vein Orfice.
R. Rai, E. Trivedi, I. Shaikh, S. Nagral, N. Doctor.
HPB & Transplant Surgery, Fortis Hospital, Mulund, Mumbai, Maharashtra, India
From January 2013 to February 2016 total of 21 patients underwent consecutive Living Donor Liver Transplant in our center. All patients were transplanted using right…
2017 American Transplant Congress
Propensity-Score Matched Comparison of Lung Transplant Recipients of Age <70 and ≥70 Years.
A. Kashem,¹ S. Keshavamurthy,¹ J. Gomez-Abraham,¹ T. Yoshizumi,¹ H. Zhao,² F. Cordova,³ G. Criner,³ Y. Toyoda.¹
¹Cardiovascular Surgery, Temple University, Philadelphia, PA; ²Clinical Sciences, Temple University, Philadelphia, PA; ³Thoracic and Pulmonary Medicine, Temple University, Philadelphia, PA
Purpose: To validate the utilization of lung transplantation (LTx) recently in older recipients, we compared the survival outcome of the LTx recipients of age <70…